English  |  正體中文  |  简体中文  |  總筆數 :2831849  
造訪人次 :  33435800    線上人數 :  705
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"湯智昕 tang chih hsin"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-25 / 356 (共15頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
中國醫藥大學 2015-11 Berberine attenuates CCN2-induced IL-1β expression and prevents cartilage degradation in a rat model of osteoarthritis. (Shan-Chi Liu);李湘萍(Hsiang-Ping Lee);黃俊寅(Chun-Yin Huang);蔡俊灝(Chun-Hao Tsai);李德茂(Te-Mao Li)*;湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-10 Osteopontin Promotes Oncostatin M Production in Human Osteoblasts: Implication of Rheumatoid Arthritis Therapy. (Chen-Ming Su);(Yi-Chun Chiang);黃俊寅(Chun-Yin Huang);許晉榮(Chin-Jung Hsu);馮逸卿(Yi-Chin Fong);湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-09 Lapatinib increases motility of triple-negative breast cancer cells by decreasing MiRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6 (Yu-Jun Hsiao);(Ming-Hsin Yeh);Yun-Ju Chen;Ju fang Liu;湯智昕(Tang Chih-Hsin);黃偉謙(Wei-Chien Huang)*
中國醫藥大學 2015-07-31 骨關節炎研究平台 湯智昕(Tang Chih-Hsin);蔡俊灝(Chun-Hao Tsai);黃元勵
中國醫藥大學 2015-07-31 102學年度年輕研究人才深耕計畫 湯智昕(Tang Chih-Hsin)
中國醫藥大學 2015-07-31 研究CTGF在cisplatin引起骨肉瘤抗藥性的角色 黃俊寅(Chun-Yin Huang);湯智昕(Tang Chih-Hsin)
中國醫藥大學 2015-07 Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis. (Huey-En Tzeng);(Po-Chun Chen);(Kai-Wei Lin);(Chih-Yang Lin);蔡俊灝(Chun-Hao Tsai);(Shao-Min Han);(Chieh-Lin Teng);(Wen-Li Hwang);(Shih-Wei Wang);湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-07 Resistin Promotes Angiogenesis in Endothelial Progenitor Cells Through Inhibition of MicroRNA206: Potential Implications for Rheumatoid Arthritis. (CHEN-MING SU);許晉榮(Chin-Jung Hsu);蔡俊灝(Chun-Hao Tsai);黃俊寅(Chun-Yin Huang);(SHIH-WEI WANG);湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-05 Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway. (Jui-Chieh Chen);(Yu-Ju Chen);(Chih-Yang Lin);馮逸卿(Yi-Chin Fong);許晉榮(Chin-Jung Hsu);蔡俊灝(Chun-Hao Tsai);蘇振良(Jen-Liang Su)*;湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-04-30 觀察CCN3對軟骨細胞MMP-13的調控作用 黃俊寅(Chun-Yin Huang);湯智昕(Tang Chih-Hsin)
中國醫藥大學 2015-04-30 觀察CCN3對造骨細胞ICAM-1的調控作用 湯智昕(Tang Chih-Hsin);黃俊寅(Chun-Yin Huang)
中國醫藥大學 2015-03-15 Extrinsic death receptor is involved in curcumin-induced cell apoptosis in human chondrosarcoma 李湘萍(Hsiang-Ping Lee);李德茂(Te-Mao Li);曹榮穎(Jung-Ying Tsao);馮逸卿(Yi-Chin Fong);湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-03 Adiponectin promotes VEGF-A-dependent angiogenesis in human chondrosarcoma through PI3K, Akt, mTOR, and HIF-α pathway 李湘萍(Hsiang-Ping Lee);(Chih-Yang Lin);(Jhao-Sheng Shih);馮逸卿(Yi-Chin Fong);(Shih-Wei Wang);李德茂(Te-Mao Li)*;湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-02-28 探討adiponectin在退化性關節炎扮演的角色 湯智昕(Tang Chih-Hsin)
中國醫藥大學 2015-02 CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells (Guan-Ting Liu);(Yuan-Li Huang);(Huey-En Tzeng);蔡俊灝(Chun-Hao Tsai);(Shih-Wei Wang);湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-02 WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression 莊淨媛(Chuang Jing Yuan);(Po-Chun Chen);(Ching-Wen Tsao);(An-Chen Chang);連銘渝(Ming-Yu Lein);(Ching-Chia Lin)*;(Shih-Wei Wang);(Chiao-Wen Lin);湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-01 Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells 蔡俊灝(Chun-Hao Tsai);蔡筱琪(Hsiao-Chi Tsai);(Ho-Ning Huang);洪誌鴻(Chi-Horng Horng);許晉榮(Chin-Jung Hsu);馮逸卿(Yi-Chin Fong);許弘昌(Horng-Chaung Hsu);黃元勵(Yuan-Li Huang)*;湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-01 CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment (Shih-Wei Wang);(Shih-Chia Liu);(Hui-Lung Sun);(Te-Yang Huang);(Chia-Han Chan);(Chen-Yu Yang);(Hung-I Yeh);(Yuan-Li Huang);(Wen-Yi Chou);(Yu-Min Lin);湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2015-01 Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells 蔡俊灝(Chun-Hao Tsai);蔡筱琪(Hsiao-Chi Tsai);(Ho-Ning Huang);洪誌鴻(Chi-Horng Horng);許晉榮(Chin-Jung Hsu);馮逸卿(Yi-Chin Fong);許弘昌(Horng-Chaung Hsu);黃元勵(Yuan-Li Huang)*;湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2014-12-31 中醫藥研究中心(中草藥研究群組) 吳永昌(Yang-Chang Wu);郭盛助(Sheng-Chu Kuo);林欣榮(Shinn-Zong Lin);韓鴻志(Horng-Jyh Harn);張建國(Jan-Gowth Chang);林振文(Lin Cheng Wen);湯智昕(Tang Chih-Hsin);郭悅雄(Yueh-Hsiung Kuo);陳悅生(Yueh-Sheng Chen);林文川(Wen-Chuan Lin);陳珠璜(Chu-Huang Chen);林應如(Ying-Ju Lin);侯庭鏞(Tin-Yun Ho);顏宏融(Hung-Rong Yen)
中國醫藥大學 2014-12 Leptin increases VEGF expression and enhances angiogenesis in human chondrosarcoma cells (Wei-Hung Yang);(Jui-Chieh Chen);(Kai-Hsiang Hsu);(Chih-Yang Lin);(Shih-Wei Wang);(Shoou-Jyi Wang);(Yung-Sen Chang);湯智昕(Tang Chih-Hsin)*
中國醫藥大學 2014-11 High Level of Plasma Matrix Metalloproteinase-11 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma (Chung-Han Hsin);(Mu-Kuan Chen);湯智昕(Tang Chih-Hsin);(Huang-Pin Lin);(Ming-Yung Chou);(Chiao Wen Lin);(Shun-Fa Yang)*
中國醫藥大學 2014-11 Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells (Feng-Yan Lin);(Yi-Hsien Hsieh);(Shun-Fa Yang);(Chang-Tai Chen);湯智昕(Tang Chih-Hsin);(Ming-Yung Chou);(Yi-Ting Chuang);(Chiao-Wen Lin);(Mu-Kuan Chen)*
中國醫藥大學 2014-11 Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells (Feng-Yan Lin);(Yi-Hsien Hsieh);(Shun-Fa Yang);(Chang-Tai Chen);湯智昕(Tang Chih-Hsin);(Ming-Yung Chou);(Yi-Ting Chuang);(Chiao-Wen Lin);(Mu-Kuan Chen)*
中國醫藥大學 2014-11 BMP-7 Enhances Cell Migration and αvβ3 Integrin Expression via a c-Src-Dependent Pathway in Human Chondrosarcoma Cells (Jui-Chieh Chen);(Shu-Ting Yang);(Chih-Yang Lin);許晉榮(Chin-Jung Hsu);蔡俊灝(Chun-Hao Tsai);蘇振良(Jen-Liang Su)*;湯智昕(Tang Chih-Hsin)*

顯示項目 1-25 / 356 (共15頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目